Low-dose growth hormone and human immunodeficiency virus-associated lipodystrophy syndrome: a pilot study

Medicin og biovidenskab

• Arthralgia 34%
• Fats 12%
• Glucose 10%
• Glucose Clamp Technique 19%
• Glucose Intolerance 17%
• Glucose Tolerance Test 16%
• Growth Hormone 61%
• HIV 44%
• HIV-Associated Lipodystrophy Syndrome 28%
• Human Growth Hormone 78%
• Insulin-Like Growth Factor I 65%
• Lipodystrophy 86%
• Placebos 11%
• Prospective Studies 10%
• Randomized Controlled Trials 10%
• Reference Values 12%
• Therapeutics 7%

Kemi

• Dose 12%
• Fat 15%
• Glucose 35%
• Growth Hormone 83%
• Insulin-Like Growth Factor I 100%
• Pharmacological Metabolism 12%